DUBLIN, September 16, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Hepatitis B and C Diagnostics Market 2016-2020" report to their offering.
The global hepatitis B and C diagnostics market is forecast to grow at a CAGR of 6.35% during the period 2016-2020.
Commenting on the report, an analyst from the research team said: One of the key trends for market growth will be high demand for biomarker-based tests. Sophisticated R&D for proteomics, nucleic acid expression, and genome sequencing has led to the emergence of molecular biomarkers. Biomarkers are proteins, genes, hormones, and other molecular entities that detect the absence or presence of a disease.
Technological advancements are driving manufacturers to develop assays that identify biomarkers in high-growth clinical areas such as infectious diseases, including hepatitis and retroviruses. Biomarker-based tests will likely replace conventional drug therapeutics and account for increased revenue and sales from personalized test devices. To better reach the market, companies are developing cost-effective biomarker-based tests. Increased approvals for devices and rise in product launches are expected to propel market growth during the forecast period.
According to the report, increase in demand for automation and system integration will be a key driver for market growth. An increasing number of consumers are opting for fully automated and semi-automated systems over conventional (manual) systems. Laboratory automation increases productivity, with high test volumes handled efficiently by few people. This type of automation helps when there is a shortage of trained technicians.
Also, automated systems provide precise results, which are otherwise difficult to achieve. Vendors are developing devices and systems that help integrate laboratory applications. For instance, the COBAS 6000 modular platform by Roche Diagnostics offers optimum efficiency and consolidation in medium- and high-volume laboratories.
The company estimates that 95% of the workload is consolidated into this system, which allows for an upgrade in workload. The system's software and graphical user interface (GUI) permit streamlined information management and offer solutions ranging from remote test ordering to sophisticated result analysis. Integrated systems with enhanced automation and efficiency are expected to fuel market growth during the forecast period.
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
- Abbott Diagnostics
- Roche Diagnostics
- Siemens Healthcare
- Allele Biotechnology
- Becton Dickinson
- Cepheid¸ Chembio Diagnostics
- Enzo Life Sciences
- OraSure Technologies
- Quest Diagnostics
- Randox Laboratories
- Vela Diagnostics
- Vital Diagnostics
- ZEUS Scientific
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Reimbursement scenario: An overview
PART 06: Market landscape
PART 07: Market segmentation by procedure
PART 08: Market segmentation by disease
PART 09: Geographical segmentation
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
PART 16: Key vendor analysis
PART 17: Appendix
PART 18: About the Author
For more information about this report visit http://www.researchandmarkets.com/research/k7gvbk/global_hepatitis
Related Topics: Infectious Disease Testing
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets